Bery Group has completed nearly 100 million yuan in B1 and B2 financing rounds. The B1 round was solely invested by BGI Songhe, while the B2 round was led by Tsingke Industrial Investment, with participation from multiple institutions, existing shareholders, and strategic investors. The proceeds will primarily fund the R&D of new materials and intelligent protein purification systems, and accelerate global commercialization. Anchored in materials science as its core foundational technology, the company develops upstream and downstream life science tools centered on protein research. It owns three major brands and a portfolio of more than 300 purification products, achieving three 100% targets and meeting the needs of all biopharmaceutical scenarios. In April this year, the company's new headquarters and Huai'an precast gel production center were put into operation, and its precast gel products now rank first in nationwide shipment volume. The company continues to advance its global and intelligent strategic layout and has launched relevant AI agents. Multiple stakeholders have shared their perspectives on this financing round and the company's development.